Edition:
United Kingdom

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

2.01USD
23 Feb 2018
Change (% chg)

$0.06 (+3.08%)
Prev Close
$1.95
Open
$1.89
Day's High
$2.08
Day's Low
$1.86
Volume
46,401
Avg. Vol
70,753
52-wk High
$6.17
52-wk Low
$0.98

Chart for

About

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The... (more)

Overall

Beta: 0.46
Market Cap(Mil.): $52.33
Shares Outstanding(Mil.): 37.11
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Aevi Genomic Medicine Files For Resale Of Up To 26.2 Mln Shares Of Co's Common Stock By Selling Stockholders

* AEVI GENOMIC MEDICINE INC FILES FOR RESALE OF UP TO 26.2 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text - http://bit.ly/2kEddlX Further company coverage:

08 Dec 2017

BRIEF-Aevi Genomic Medicine Announces New Appointment To Its Board Of Directors

* AEVI GENOMIC MEDICINE ANNOUNCES NEW APPOINTMENT TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

04 Dec 2017

BRIEF-Aevi Genomic Medicine Q3 loss per share $0.23

* Aevi Genomic Medicine reports third quarter 2017 financial results

02 Nov 2017

Earnings vs. Estimates